Company: BSX
Filing Date: 2025-08-01
Form Type: 10-Q
Source: 0000885725-25-000041
Chunk: 64

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-08-01
Form: 10-Q
Item: Part I, Item 1
Chunk 64
---
 millions)June 30, 2025December 31, 2024Restricted cash and restricted cash equivalents$109 $111 Derivative assets89 305 Other415 414  $613 $831 Property, plant and equipment, net As of(in millions)June 30, 2025December 31, 2024Land$147 $144 Buildings and improvements2,152 2,019 Equipment, furniture and fixtures3,903 3,630 Capital in progress1,041 1,035  7,243 6,827 Less: accumulated depreciation3,783 3,533  $3,461 $3,294 Depreciation expense was $111 million for the second quarter of 2025, $98 million for the second quarter of 2024, $217 million for the first six months of 2025 and $188 million for the first six months of 2024.Other long-term assets As of(in millions)June 30, 2025December 31, 2024Restricted cash equivalents$98 $80 Operating lease right-of-use assets492 449 Investments626 555 Indemnification asset206 188 Other442 481  $1,864 $1,754 

24

Accrued expenses As of(in millions)June 30, 2025December 31, 2024Legal reserves$131 $177 Payroll and related liabilities1,183 1,288 Rebates573 494 Contingent consideration73 63 Other836 751  $2,797 $2,773 Other current liabilities As of(in millions)June 30, 2025December 31, 2024Deferred revenue$313 $306 Taxes payable173 268 Other467 313  $952 $887 Other long-term liabilities As of(in millions)June 30, 2025December 31, 2024Legal reserves$169 $149 Accrued income taxes387 357 Contingent consideration294 108 Operating lease liabilities440 401 Deferred revenue349 329 Other744 527  $2,383 $1,870 

25

NOTE G – INCOME TAXES The following table provides a reconciliation of our reported tax rate to the rate from continuing operations: